mohamed magdy elsadek atta|Publications

Benha University

Staff Search: Go

You are in:Home/Publications
Prof. mohamed magdy elsadek atta :: Publications:

Research Fields

HEPATOLOGY GASTROENTEROLOGY & INFECTIOUS DISEASES

Number of publications is 57

Title

1-Clinical significance of vascular endothelial growth factor in hepatitis C related hepatocellular carcinoma in Egyptian patients

Abstract' | Full paper

2- Early rebleeding and mortality in post HCV cirrhotic patients with esophageal variceal bleeding after band ligation: predictive factors and value of vascular endothelial growth factor.

3-Hypothyroidism is the prevalent thyroid dysfunction encountered during combined Interferon / Ribavirin (IFN / RBV) therapy in chronic hepatitis C patient.

4-Lymphocyte subgroups , tumour necrosis factor alpha and interleukin-6 in ascitic fluid and serum of patients with and sontaneous bacterial peritonitis at Benha university hospital.Egyptian

5-Seroprevelance of Toxoplasmosis among Females in Rural Areas, Qalubeya Governorate.

6-Assessment of eight non-invasive markers of liver fibrosis in Egyptian patients with chronic hepatitis C.

Abstract' | Full paper

7-Tolemerase Reverse Transcriptase Gene Expression as a Tumor Marker for Hepatocellular Carcinoma.

Abstract' | Full paper

8-Value of serum anti-p53 antibodies as a prognostic factor in Egyptian patients with hepatocellular carcinoma.

9-Prognostic value of serum anti- P53 antibody in Egyptian patients with hepatocellular carcinoma.

10-Spontaneous bacterial peritonitis: a clinical and microbiological study.

11-Study of pancreatic enzymes in patients with liver diseases.

12-Non-invasive prediction of esophageal variceal presence and bleeding by duplex ultrasonography.

13-Low Incidence of Helicobacter pylori Infection in Patients with Duodenal Ulcer and Chronic Liver Disease Scandinavian

14-Shistosomiases-Associated glomerulopathy a field studies from Nile delta. African

15-Study of Helicobacter Pylori in dyspepsia with and without non-steroidal anti-inflammatory drugs (NSAIDs) intake and/or chronic liver disease (CLD) with the effect of therapy.

16-Serum hepatocyte growth factor in shistosomal and non shistosomal chronic liver diseases.

Abstract' | Full paper

17-The importance of detecting circulating Toxoplasma antigens in human cases.

18-Signficance of alfa-fucosidase and n-acetylneuraminic acid as markers for hepatocellular carcinoma.

19-Evaluating the detection of circulating filarial antigen in diagnosis of bancroftian filariasis and filarial hydrocele.

20-High prevalence of hepatitis C virus RNA in saliva of patients with chronic HCV infection.

21-A study of Helicobact pylori in patients with and without chronic liver disease.

22-Sensitivity and specificity of alpha-L-fucosidase as a tumor marker in early diagnosis of hepatocellular carcinoma.

23-Toxoplasma infections distinguished by avidity of IgG.

24-The value of splenomegaly in predicting the source of upper gastrointestinal bleeding.

25-Detection of Ccryptosporidium antigen in stool sample among diarrhoeic children.

26-Evaluation of ELISA in detection of circulating antigen of bancroftian filariasis.

27-Bleeding oesophageal varices associated with hepatic schistosomiasis in Egypt.

28-Alpha interferon in chronic viral hepatitis: A controlled study.

29-The effect of treatment on circulating schistosomal antigens and hepatic periportal fibrosis in children with schistosomiasis mansoni.

30-Responders and non-responders to interferon in patient with hepatitis C infection: A comparative retrospective study.

31-Bleeding oesophageal varices in Egypt: Analysis of 362 patients.

32-Effect of labetalol on portal pressure and estimated hepatic blood flow in patients with schistosomal hepatic fibrosis.

33-Effects of propranolol therapy on portal haemodynamics in patient with hepatic schistosomiasis.

34-A study of the hormonal immunity and (HLA) tissue typing in different clinical forms of amoebiasis.

35-Endoscopic and histopathologic appearance of the gastric mucosa in patients with chronic liver diseases.

36-Endoscopic mucosal lesions in diagnosis of giardiasis.

37-Efficacy of two different dose levels of ofloxacin in drug resistant cases of enteric fever.

38-Gastroesophageal endoscopic features in patients with chronic liver disease.

39-Serum prealbumin concentrations in acute and chronic liver diseases.

40-Value of duplex ultrasonography in schistosomal hepatic lesions.

41-Effect of sclerotherapy versus splenectomy – devascularization on haemostatic picture of patients with bleeding oesophageal varices.

42-Study of HBV markers and HLA typing in chronic liver diseases (CLD).

43-Atypical virus B hepatitis in Egypt.

44-Peptic ulcer in chronic liver disease patients: A novel approach.

45-Serological and parasitological examination of some patients with manifestations suggestive leishmaniasis.

46-Gastric fluid acidity in peptic lesions.

47-The value of salt restriction in the treatment of hepatic ascites.

48-Prevelance of hepatitis B surface antigen in serum and ascetic fluid of patients with chronic liver diseases.

49-Evaluation of different doses of praziquantel in the cure of intestinal schistosomiasis.

50-Study of plasma level of fibronectin in different stages of schistosomiasis.

51-ELISA in detection of Entamoeba histolytica antigens in stools.

52-The effect of propranolol on portal hypertension and prevention of recurrent variceal bleeding in schistosomal and non-schistosomal patients.

53-Evaluation of the different methods of diagnosing schistosomiasis.

54-Eosinophilia and schistomal egg count.

55-Urinary infections associated with chronic salmonellosis.

56-Hepatitis B surface antigenemia in hepatosplenic patients with active schistosomiasis.

57-Endoscopic and immunohistopathological study of gastric, duodenal, and colonic mucosa in schistosomal polyposis

Google Scholar

Acdemia.edu

Research Gate

Google Plus

Youtube

Wordpress

Instagram

Mendeley

Zotero

Evernote

ORCID

Scopus